title: Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.
abstract: Guidelines released by two groups this year recommend resistance testing for all recently infected patients beginning treatment. However, both groups also suggest considering resistance testing for drug-naive patients whose infections are not recent, particularly if the prevalence of resistance in the patient's area is 5% or greater.
mesh_terms: D019380:Anti-HIV Agents / Q000494:pharmacology*; D002487:Centers for Disease Control and Prevention, U.S.; D024882:Drug Resistance, Viral; D005838:Genotype; D017408:Guidelines as Topic; D006678:HIV / Q000187:drug effects / Q000235:genetics; D015658:HIV Infections / Q000821:virology*; D006801:Humans; D011159:Population Surveillance; D014481:United States
chemical_list: D019380:Anti-HIV Agents